Submitted on Thursday 29th March 2018
Rejected on Thursday 19th April 2018
Current status: Rejected
Rejection code: irrelevant (see below for details)
Make Epidiolex available on prescription for childhood Epilepsy
Epidiolex is a CBD (Cannabidiol) based drug produced by GW Pharmaceuticals in the UK for treating childhood epilepsy that has completed its 3rd stage trials and is just about to be prescribed for the first time in pharmacies in Denver Colorado in the USA
GW’s Epidiolex®
Epidiolex is GW’s lead cannabinoid product candidate and is a proprietary oral solution of pure plant-derived cannabidiol, or CBD. GW’s Epidiolex development is initially concentrating on severe, orphan, early-onset, treatment-resistant epilepsy syndromes including Dravet syndrome, Lennox-Gastaut syndrome (LGS), Tuberous Sclerosis Complex (TSC) and Infantile Spasms (IS).
You can't sign this petition because it was rejected. But you can still comment on it here at Repetition.me!
The Government e-Petitions Team gave the following reason:
We can only accept petitions about matters that the UK Government or the House of Commons are responsible for.
The UK Government and Parliament don't licence medicines or advise doctors on what to prescribe.
The European Medicines Agency and the Medicines and Healthcare products Regulatory Agency are responsible for licensing medicines.
The pharmaceutical company applied to EMA for a licence in February 2018.
You can find out more about unlicensed medicines and prescriptions here:
www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/prescribing-and-managing-medicines-and-devices/prescribing-unlicensed-medicines
3.14.135.82 Thu, 21 Nov 2024 15:45:42 +0000
